(NASDAQ:SCNX), TAMPA, FL, Jan. 21, 2025 (GLOBE NEWSWIRE) — SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a Specialty Pharma company with a novel pipeline of brand products, is pleased to announce the participation of Narasimhan Mani, Ph.D., MBA (President of Scienture, LLC) as an invited speaker and panelist at the 8th Annual Conference of The Society for […]

(NASDAQ:BTCS), Silver Spring, MD, Jan. 21, 2025 (GLOBE NEWSWIRE) — BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a leader in blockchain infrastructure and technology, is pleased to announce its participation in a fireside chat hosted by H.C. Wainwright & Co. The event is open to both institutional investors and the general public and will

Edge AI Innovator Launches Groundbreaking Platform, Expands Technological Footprint for Commercial and Defense Applications Latent AI, a leader in edge AI solutions for national security applications, today announced significant technological advancements and market momentum, highlighted by breakthrough deployments across U.S. defense agencies, a landmark commercial partnership with FSP in sports technology, and the expansion of

One in five healthcare organizations reported a change in senior leadership (21%) or lawsuits (19%) as attack consequences, compared to 13% among other sectors surveyed. Netwrix, a vendor specializing in cybersecurity solutions focused on data and identity threats, surveyed1,309 IT and security professionals globally and today released findings for the healthcare sectorbased on the data

Effective immediately, Bill Kerfin has been appointed President of Amsted Automotive. Kerfin assumes this role after serving as Executive Vice President of Amsted Automotive since October 1, 2023. https://mma.prnewswire.com/media/2602032/Amsted_Automotive_CEO_2025_Bill_Kerfin.jpg Kerfin's career reflects an extensive track record of leadership and expertise within the Amsted family of businesses and beyond. He previously served as Chief Financial Officer

(NYSE:ENFN),(NYSE:SSTK),(NYSE:CWAN),(NYSE:JNJ),(NYSE:GETY),(NYSE:URI),(NASDAQ:HEES),(NASDAQ:ITCI), BALA CYNWYD, Pa., Jan. 21, 2025 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. Enfusion, Inc. (NYSE – ENFN) Under the

FORT LAUDERDALE, FL / ACCESS Newswire / January 21, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that its wholly owned Canadian subsidiary, Nora Pharma Inc., has launched two new generic prescription drugs. The newly

Presentation Scheduled for Wednesday, January 29th at 10:30 AM ET JACKSONVILLE, FL / ACCESS Newswire / January 21, 2025 / Duos Technologies Group, Inc. ("Duos" or the "Company") (Nasdaq:DUOT), is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference will take place January 28-30,

PASADENA, CA / ACCESS Newswire / January 21, 2025 / The Now Corporation (OTC PINK:NWPN), an emerging leader in solar energy and utility solutions, announces its strategic focus on expanding into the California community solar market. This opportunity arises as California introduces new legislation, Assembly Bill 2316, designed to incentivize community solar projects that integrate

The Companies intend to first initiate a Phase 2a clinical trial evaluating Xyngari™ with Daxxify® to treat primary axillary hyperhidrosis – If successful, the Companies may explore clinical development in additional indications – Xyngari™ with Daxxify® has the potential to be the first approved needle-free intradermal delivery of a botulinum toxin product – SAN DIEGO,